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Abstract
Background: Toll-like receptors (TLRs) recognize pathogen-associated molecular patterns and play a crucial role in the 
host's innate immune response. Genetic variations in TLR genes may influence host-viral interactions and might impact 
upon the risk of mother-to-child transmission (MTCT) of Human Immunodeficiency Virus type 1 (HIV-1). The aim of this 
study was to investigate the influence of genetic variants of TLR 9 gene on MTCT.
Methods: Three hundred children (118 HIV-1-infected and 182 HIV-1-uninfected) born to HIV-1-infected mothers were 
studied. Single nucleotide polymorphisms (SNPs) NM_017442.2: c.4-44G > A (rs352139) and c.1635A > G (rs352140) of 
the TLR9 gene were genotyped by TaqMan allelic discrimination assay. Statistical analyses were performed using 
SNPStats program.
Results: When considered separately, neither of the two SNPs was significantly associated with risk of HIV-1 infection. 
However, the [A;A] and [G;G] haplotypes were associated with a higher risk of HIV-1 infection compared to the 
prevalent [G;A] haplotype [odds ratio (OR) = 3.16, 95% confidence interval (CI) 1.24-8.03, p = 0.016, and OR = 5.54, 95% 
CI 1.76-17.50, p = 0.004, respectively].
Conclusions: Overall, results demonstrate a significant correlation between specific genetic variants of the TLR9 gene 
and risk of MTCT of HIV-1, thus confirming a critical role of innate immunity in perinatal HIV-1 infection. Strategies 
aimed at modulating innate immunity might be useful for future treatment of pediatric HIV-1 infection and AIDS.
Background
Mother-to-child transmission (MTCT) is the main
source of pediatric HIV-1 infection. MTCT of HIV-1 is
multifactorial, with plasma viral load and mode of deliv-
ery being important maternal factors [1]. Innate immu-
nity may contribute to host-viral interactions and impact
the risk of MTCT of HIV-1 that occurs when the adaptive
immune system is still under development.
Toll-like receptors (TLRs) are type 1 transmembrane
proteins differentially expressed among immune cells.
They recognize and bind to conserved pathogen-associ-
ated molecular patterns shared by large groups of micro-
organisms, and trigger the activation of signal
transduction pathways, that in turn induce dendritic cell
maturation and cytokine production [2]. These receptors
play a central role in the activation of innate immunity
[3]. A growing body of data supports a role of specific sin-
gle nucleotide polymorphisms (SNPs) in several TLR
genes in modulating the risk of bacterial and viral infec-
tions. Few studies have analyzed the role of TLR SNPs in
clinical HIV-1 infection. An association between a TLR4
SNP and a higher susceptibility to tuberculosis in HIV-1-
infected patients in Tanzania has been reported [4], and a
functional TLR8 variant has been found to be associated
with HIV-1 clinical outcome [5]. Recently, two SNPs in
the TLR9 gene, the c.4-44G > A (rs352139) and the
c.1635A > G (rs352140), were linked to progression of
HIV-1 disease and viral load in adult patients [6-8]. TLR9
recognizes unmethylated cytidine-phosphate-guanosine
(CpG) DNA motifs in bacteria and viruses [9], and is
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expressed in a wide variety of human cells, including plas-
macytoid dendritic cells.
To date, the relationship between TLR gene polymor-
phisms and perinatal HIV-1 infection has not been inves-
tigated. The present study focuses on the role of c.4-44G
> A and c.1635A > G SNPs in the TLR9 gene in MTCT of
HIV-1 by analyzing a large cohort of HIV-1-infected and
HIV-1-uninfected infants, all born to HIV-1-infected
mothers.
Methods
Patients
The study population included 300 children born to HIV-
1-seropositive mothers between 1984 and 1996, whose
virological analyses for diagnosis of HIV-1 infection were
conducted at the AIDS Reference Center of Padova Uni-
versity. Inclusion criteria were the known HIV-1-sero-
positive status of the mother at delivery, the absence of
antiretroviral prophylaxis during gestation and/or at
delivery, and ethnicity. All children were white Caucasian;
282 (94%) were born by vaginal delivery and 18 by caesar-
ean section, and none was breastfeed. Diagnosis of HIV-1
infection was performed by virus isolation and poly-
merase chain reaction (PCR) [10]. For all children
included in this study, 118 HIV-1-infected and 182 HIV-
1-uninfected, the infection was confirmed by disease
onset and/or persistence of HIV-1 antibody after 18
months of age, while lack of infection was confirmed by
the loss of HIV-1 antibodies. The study was performed in
accordance with the Helsinki Declaration and was
approved by the Ethics Committee of the Azienda
Ospedaliera di Padova. An informed consent regarding
the use of biological specimens for research purposes was
obtained from parents or legal guardians.
SNP Analysis
Genomic DNA was extracted from peripheral blood
mononuclear cells with the QIAamp DNA Blood mini kit
(Qiagen, Hilden, Germany), according to the manufac-
turer's instructions. Polymorphic sites in genomic DNA
were analyzed by TaqMan allelic discrimination assay.
Primers and probes for NM_017442.2: c.4-44G > A
(rs352139) and c.1635A > G (rs352140) genotyping were
designed with Primer Express software (version 3.0,
Applied Biosystems) (GeneBank reference sequence
NM_017442.2). The primers were: 5'-CAGGTAGGGCT-
TGGAGAGAGG-3' and 5'-TGGGAGGGCTGTGT-
GAGTG-3' for c.4-44G > A and 5'-TGGACCTCTA
CCACGAGCACT-3' and 5'-AAAGGGCTGGCTGTTG-
TAGCT-3' for c.1635A > G. The TaqMan MGB allele-
specific probes were: FAM-5' TGGAGGTGGAGCTG-3'-
MGB and VIC-5'-TGGGTGGAGGTAGAG-3'-MGB for
c.4-44G > A, FAM-5'-ACGGAGCTACCGCGA-3'-MGB
and VIC-5'-CGGAGCTACCACGAC-3'-MGB for
c.1635A > G. PCR was performed in the ABI PRISM 7700
thermal cycler (Applied Biosystems) according to stan-
dard procedures. Thermal cycling conditions were 2 min-
utes at 50°C, 10 minutes at 95°C, and 45 cycles each of
95°C for 15 seconds and 62°C for 1 minute. The geno-
types were assigned using the Sequence Detection Sys-
tem software (version 1.9, Applied Biosystems), analyzing
the threshold cycle of amplification curves. Accuracy of
genotyping was confirmed by direct sequencing of ran-
domly selected samples, as previously described [11],
using the same primers used in Taqman assay.
Quantification of HIV-1 RNA in plasma
Plasma HIV-1 RNA levels were determined by reverse
transcriptase-PCR (Roche Amplicor Monitor System,
New Jersey, USA) according to the manufacturer's
instructions. The lower limit of detection of this assay
was 50 HIV-1 RNA copies/ml of plasma using the ultra-
sensitive protocol.
Statistical analysis
Estimation of the power of the study to detect an associa-
tion between SNPs and HIV-1 infection was evaluated
using the genetic power calculator available at http://
pngu.mgh.harvard.edu/~purcell/gpc/. The study had 80%
power to detect significant (p < 0.05) effects with odds
ratio (OR) greater than 2 for the A allele of c.4-44G > A
and G allele of c.1635A > G. Haplotype frequencies were
estimated from genotype frequencies using the Expecta-
tion-Maximization algorithm coded into the SNPStats
program [12]. All the statistical analyses, including the
Hardy-Weinberg equilibrium test, linkage disequilibrium
estimation, as well as the association of SNP genotypes
and haplotypes with HIV-1 infection status, were per-
formed using SNPStats software [12]. To increase the
power of the study, four genetic models (co-dominant,
dominant, recessive, and additive) were considered.
Moreover, the effect of viral load on the association of
SNPs and haplotypes with HIV-1 infection was tested
with multivariate regression analysis, implemented in the
SNPStats program. ORs and 95% confidence intervals
(CI) were calculated for each group compared to the ref-
erence class (homozygous genotype for the prevalent
allele); p values were derived from the Chi-square test.
The Bonferroni correction of the significance level was
applied to account for multiple testing.
Results
To analyze the impact of c.4-44G > A and c.1635A > G
SNPs on HIV-1 perinatal infection, a cohort of HIV-1-
infected (n = 118) and exposed HIV-1-uninfected (n =
182) children was analyzed with different genetic models.
Genotype and allele frequencies for the two SNPs were in
Hardy-Weinberg equilibrium in both groups and were inRicci et al. Journal of Translational Medicine 2010, 8:49
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agreement with frequencies reported in the NCBI data-
base on the Caucasian population. c.4-44GA was the
most frequent genotype in both HIV-1-uninfected and
HIV-1-infected children, while c.1635AG was the most
frequent genotype in HIV-1-uninfected children. c.4-
44GG and c.1635AA genotypes had a higher prevalence
in HIV-1-infected infants. However, the two SNPs
showed no significant association with the risk of HIV-1
infection in the codominant model (Table 1), or in other
genetic models considered (data not shown).
Linkage disequilibrium analysis confirmed a strong dis-
equilibrium level between the two SNPs with D' = 0.87
and r2 = 0.74. To investigate their combined effect, given
their close proximity, haplotype frequencies were esti-
mated in both groups of children. [G;A] was the most fre-
quent haplotype in both HIV-1-uninfected and HIV-1-
infected children, while the [G;G] and [A;A] haplotypes
had a low frequency, but were more prevalent in HIV-1-
infected infants, leading to a significantly increased risk
of MTCT of HIV-1 compared to the most frequent [G;A]
and [A;G] haplotypes (Table 1).
Values of maternal viral load at delivery were available
in a subgroup of 109 infants (median 8790 HIV-1 RNA
copies/ml of plasma, range 40-2106650 HIV-1 RNA cop-
ies/ml of plasma). Analyses of allele and genotype fre-
quencies and the Hardy-Weinberg equilibrium in this
subgroup were in agreement with those in the entire
cohort (data not shown). For prevention of MTCT of
HIV-1, highly active antiretroviral therapy was recently
recommended for all women with HIV-1 RNA levels of ≥
1000 copies/ml of plasma [13]. A further analysis was
thus performed categorizing mothers according to low (<
1000 HIV-1 RNA copies/ml of plasma) and high (> 1000
HIV-1 RNA copies/ml of plasma) viral load. As for the
larger cohort, while neither of the two SNPs was signifi-
cantly associated with a risk of HIV-1 infection, the [G;G]
haplotype remained associated with a higher risk of
MTCT of HIV-1 after adjustment for maternal viral load
(OR = 10.04, 95% CI 1.70-59.37, p = 0.012; p = 0.017 sig-
nificance level after Bonferroni correction).
Discussion
TLRs play a central role in innate immunity and a num-
ber of genetic association studies suggest that some TLR
polymorphisms may be associated with susceptibility to
different diseases. There is convincing evidence that
common TLR SNPs modulate immune function by modi-
fying the control of inflammatory cascades, elaboration
of effector molecules, pathogen killing, and interactions
with the adaptive immune response [14]. TLR9 plays a
pivotal role in the induction of first-line defense mecha-
nisms of the innate immune system and triggers effective
adaptive immune responses to different bacterial and
viral pathogens [15,16]. A few genetic polymorphisms
within the TLR9 gene have been reported to be associ-
ated with a variety of inflammatory and infectious dis-
eases [6-8,17,18].
Table 1: Frequencies of TLR9 genotypes and haplotypes and risk of HIV-1 infection.
SNP Genotypes Uninfected 
children
(n = 182)
Infected 
children
(n = 118)
OR 95% CI p
LCL UCL
c.4-44G > A(rs352139) GG 0.29 0.36 1 0.48
GA 0.50 0.44 0.72 0.42 1.22
AA 0.31 0.20 0.80 0.42 1.53
c.1635A > G(rs352140) AA 0.31 0.39 1 0.20
AG 0.48 0.38 0.62 0.37 1.06
GG 0.21 0.23 0.86 0.46 1.62
Haplotypes G;A 0.53 0.51 1
A;G 0.44 0.36 0.92 0.65 1.30 0.63*
A;A 0.02 0.07 3.16 1.24 8.03 0.016*
G;G 0.01 0.06 5.54 1.76 17.50 0.0038*
LCL, lower confidence limit; UCL, upper confidence limit.
* The significance level after Bonferroni correction for multiple testing is 0.017 instead of 0.05.Ricci et al. Journal of Translational Medicine 2010, 8:49
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Our study investigates for the first time the relationship
between c.4-44G > A and c.1635A > G SNPs of TLR9 and
MTCT of HIV-1, revealing that the TLR9 [A;A] and
[G;G] haplotypes are associated with a significantly
increased risk of MTCT of HIV-1. Genetic variations of
TLR9, as a key gene of innate immunity, could impact on
immunological downstream responses that are critically
important for host defenses. The function of these SNPs
and haplotypes is still largely unknown. Neither of the
two SNPs induces amino acid change, but several find-
ings suggest that they may affect TLR9 expression
[7,8,17]. Functional studies demonstrated a critical role
for the G allele of the c.4-44G > A SNP on TLR9 expres-
sion [17], and the c.4-44GG genotype was found to be
associated with slow disease progression in HIV-1
infected adults [6]. The c.1635A > G SNP was also found
to influence the progression of HIV-1 disease [6-8]. Fur-
thermore, association of the c.1635A > G with CD4 cell
count and viral load has suggested a role of this SNP in
TLR9-mediated immune activation [7,8]. It has been
demonstrated that sooty mangabeys have reduced levels
of innate immune activation during apathogenic simian
immunodeficiency virus infection and that plasmocytoid
dendritic cells from these animals produce markedly low
levels of interferon α in response to TLR9 ligands [19].
Specific haplotypes in the TLR9 gene might influence the
functional ability of TLR9 to elicit a defense mechanism
by affecting susceptibility or resistance to infections.
Conclusions
In conclusion, our results demonstrate an important role
of genetic variants of the TLR9 gene in modulating the
risk of MTCT of HIV-1, thus confirming the relevance of
innate immunity in perinatal HIV-1 infection. This
knowledge may be valuable in the development of new
therapeutic strategies including the use the specific adju-
vants. More studies are needed to evaluate if strategies
aimed at modulating innate immunity might be useful for
future treatment of pediatric HIV-1 infection and AIDS.
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